Sensorion SA
Sensorion SA, a biotechnology company, develops drug candidates for the treatment of inner ear disorders in France. The company's product portfolio includes SENS-401 SSNHL, which has completed Phase 2b clinical trial for the treatment of Sudden Sensorineural Hearing Loss; SENS-401 CIO that is in Phase 2a clinical trial for the treatment of Cisplatin-Induced Ototoxicity; and SENS-401 Cochlear, whi… Read more
Sensorion SA (ALSEN) - Total Liabilities
Latest total liabilities as of June 2025: €16.36 Million EUR
Based on the latest financial reports, Sensorion SA (ALSEN) has total liabilities worth €16.36 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Sensorion SA - Total Liabilities Trend (2011–2024)
This chart illustrates how Sensorion SA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Sensorion SA Competitors by Total Liabilities
The table below lists competitors of Sensorion SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
UY Scuti Acquisition Corp.
NASDAQ:UYSC
|
USA | $58.23 Million |
|
Starry Sea Acquisition Corp Ordinary Shares
NASDAQ:SSEA
|
USA | $27.23K |
|
Motorcycle Holdings Ltd
AU:MTO
|
Australia | AU$236.97 Million |
|
PT Sinergi Inti Andalan Prima Tbk
JK:INET
|
Indonesia | Rp93.09 Billion |
|
Daewonkangup
KO:000430
|
Korea | ₩700.20 Billion |
|
GIC Housing Finance Limited
NSE:GICHSGFIN
|
India | ₹90.84 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down Sensorion SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.90 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sensorion SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sensorion SA (2011–2024)
The table below shows the annual total liabilities of Sensorion SA from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €17.14 Million | +29.57% |
| 2023-12-31 | €13.23 Million | -22.47% |
| 2022-12-31 | €17.06 Million | +13.47% |
| 2021-12-31 | €15.03 Million | +57.85% |
| 2020-12-31 | €9.52 Million | -61.72% |
| 2019-12-31 | €24.88 Million | +317.68% |
| 2018-12-31 | €5.96 Million | +55.06% |
| 2017-12-31 | €3.84 Million | +17.86% |
| 2016-12-31 | €3.26 Million | -11.91% |
| 2015-12-31 | €3.70 Million | +47.11% |
| 2014-12-31 | €2.52 Million | +7.83% |
| 2013-12-31 | €2.33 Million | +561.52% |
| 2012-12-31 | €352.61K | +67.50% |
| 2011-12-31 | €210.51K | -- |